LONDON (Reuters) – Real-world data on the effectiveness of Oxford and AstraZeneca’s COVID-19 vaccine in older people from its rollout in Britain should help inform decision making in other countries, Oxford Vaccine Group Director Andrew Pollard said on Tuesday.
Asked if other countries should look at real world data from Public Health England, Pollard said: “I think that the scientific committees in each of these countries will be doing exactly that over the days ahead.
“The strength of evidence that we’re now seeing… all of that is being accessed by scientific committees in different countries, and I’m sure will help support their decision making,” he told BBC radio.
(Reporting by Alistair Smout; editing by Michael Holden)
